Marketing of units or shares of EU AIFs in the home Member State of the AIFM

Revision as of 15:39, 30 January 2015 by Amwelladmin (talk | contribs) (Created page with "{{aifmdsnap|31}} {{aifmdanatomy}}")

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Paragraph 31, AIFMD

AIFMD, 31
Template:AIFMD 31
(view template)

AIFMD

This is an article about Alternative Investment Funds Management Directive (2011/61/EU (EUR Lex)) and the AIFMD Implementing Regulation 231/2013 (EUR Lex).

Navigation - directive 2011/61/EU (EUR Lex): 21 | 21(8) | 21(11) | 21(14) | 36 (depo-lite) | 36(1)
Navigation - implementing regulation 231/2013 (EUR Lex): DR76 (objective reason) | DR91 (reporting obligations for prime brokers)
AIFMD Anatomy
Anatomy™: AIFMD | CASS | COBS | Conference calls | Confis | CRR | CSA | EMIR | Equity Derivatives | FOA PCA | FUND | GMRA | GMSLA | ISDA | OSLA | PB | Swapclear | UCITS

Retrieved from "https://jollycontrarian.com/index.php?title=Marketing_of_units_or_shares_of_EU_AIFs_in_the_home_Member_State_of_the_AIFM&oldid=8827"